Biogen (BIIB) stock forecast for 2024. Forecast tables and graphs.







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Biogen (BIIB) stock forecast for 2024

Updated: July 22, 2024 (20:36)

Sector: Healthcare

The share price of Biogen Inc. (BIIB) now

What analysts predict: $280.13
52-week High/Low: $280.42 / $189.44

50/200 Day Moving Average: $226.9 / $231.96

This figure corresponds to the Average Price over the previous 50/200 days. For Biogen stocks, the 50-day moving average is the resistance level today.

For Biogen stocks, the 200-day moving average is the resistance level today.

Are you interested in Biogen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biogen stock price in 2024. How much will one Biogen share be worth in 2024? Is it worth taking profit / loss on BIIB stock now or waiting? What are analysts' forecasts for Biogen stock?

We forecast Biogen stock performance using neural networks based on historical data on BIIB stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Biogen Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Biogen analysts is $280.13. Today 200 Day Moving Average is the resistance level (231.96 $). 50 Day Moving Average is the support level (226.9 $).




Historical and forecast chart of Biogen Inc. stock

The chart below shows the historical price of Biogen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BIIB stock price can be found in the table below.


Biogen is an international biotechnology company that discovers, develops and provides drugs for the treatment of multiple sclerosis (MS) and other hematological, neurodegenerative, autoimmune and other diseases to patients around the world. Biogen is at the forefront of new drug research for neurological diseases and rare genetic diseases.

The company was founded in Geneva (Switzerland) in 1978 by several renowned and forward-thinking biologists. Later one of the founders, Ph.D. Walter Gilbert, received the Nobel Prize in Chemistry for the DNA sequencing method. And in 1993, another founder, Phillip Sharp, received the Nobel Prize in Physiology or Medicine for discovering and showing that the genes of higher organisms have a “discontinuous” structure.

Official site of the company

Biogen (BIIB) Forecast for 2024

Month Target Pes. Opt. Vol., %
Aug 247.59 239.27 270.17 11.44 %
Sep 271.06 258.38 289.93 10.88 %
Oct 279.20 272.16 286.57 5.03 %
Nov 249.71 226.94 257.50 11.87 %
Dec 260.80 242.33 285.84 15.22 %

Biogen information and performance

Biogen Address

225 BINNEY STREET, CAMBRIDGE, MA, US

Market Capitalization: 32 963 158 000 $

Market capitalization of the Biogen Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BIIB shares in the company outstanding by the market price of one share.

EBITDA: 2 519 800 000 $

EBITDA of Biogen is earnings before interest, income tax and depreciation of assets.

PE Ratio: 28.34

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 6.24

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 7.99

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.011
Quarterly Revenue Growth YOY: -0.07
Trailing PE: 28.34

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 13.0

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.568

Enterprise Value (EV) /Revenue

EV To EBITDA: 17.22

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 145597000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Biogen price target for 2024 by month


Target values for the price of one Biogen share for Aug 2024.

The weighted average target price per Biogen share in Aug 2024 is: 247.59.
In Aug, the Positive dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 11.437% volatility is expected.
Pessimistic target level: 239.27
Optimistic target level: 270.17

Target values for the price of one Biogen share for Sep 2024.

The weighted average target price per Biogen share in Sep 2024 is: 271.06.
In Sep, the Positive dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 10.883% volatility is expected.
Pessimistic target level: 258.38
Optimistic target level: 289.93

Target values for the price of one Biogen share for Oct 2024.

The weighted average target price per Biogen share in Oct 2024 is: 279.20.
In Oct, the Positive dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 5.027% volatility is expected.
Pessimistic target level: 272.16
Optimistic target level: 286.57

Target values for the price of one Biogen share for Nov 2024.

The weighted average target price per Biogen share in Nov 2024 is: 249.71.
In Nov, the Negative dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 11.870% volatility is expected.
Pessimistic target level: 226.94
Optimistic target level: 257.50

Target values for the price of one Biogen share for Dec 2024.

The weighted average target price per Biogen share in Dec 2024 is: 260.80.
In Dec, the Positive dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 15.219% volatility is expected.
Pessimistic target level: 242.33
Optimistic target level: 285.84



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.